Dyne Therapeutics, Inc. - Common Stock, $0.0001 par value per share (DYN)

Historical Holders from Q3 2020 to Q3 2025

Symbol
DYN on Nasdaq
CUSIP
26818M108
Type / Class
Equity / Common Stock, $0.0001 par value per share
Shares outstanding
142M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
156M
Holdings value
$1.97B
% of all portfolios
0.006%
Grand Portfolio weight change
+0.001%
Number of holders
204
Number of buys
146
Number of sells
-64
Average Value change %
+0%
Average buys %
+0.003%
Average sells %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Dyne Therapeutics, Inc. - Common Stock, $0.0001 par value per share (DYN)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
JANUS HENDERSON GROUP PLC 10.4% +3% $187M $4.43M 14.7M +2.43% JANUS HENDERSON GROUP PLC Sep 30, 2025
BlackRock, Inc. 5.8% $49.7M 6.58M BlackRock, Inc. Mar 31, 2025
Atlas Venture Fund XI, L.P. 4% $72.3M 5.71M Atlas Venture Associates XI, L.P. Sep 30, 2025
Forbion Capital Fund IV Cooperatief U.A. 4.8% $40.8M 5.4M ForDyne B.V. Mar 31, 2025
FMR LLC 4.6% -41.3% $39.2M -$21.2M 5.2M -35% FMR LLC Mar 31, 2025
RTW INVESTMENTS, LP 1.5% -72% $12.8M -$26.6M 1.69M -67.6% RTW Investments, LP Mar 31, 2025
Point72 Asset Management, L.P. 1.5% -72% $12.6M -$26.6M 1.67M -67.9% Point72 Asset Management, L.P. Mar 31, 2025

Institutional Holders of Dyne Therapeutics, Inc. - Common Stock, $0.0001 par value per share (DYN)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 156M $1.97B +$382M $12.65 204
2025 Q2 129M $1.23B +$58.2M $9.52 196
2025 Q1 122M $1.28B -$75.9M $10.46 202
2024 Q4 112M $2.63B -$30.3M $23.56 197
2024 Q3 112M $4.02B -$15.7M $35.92 201
2024 Q2 111M $3.92B +$557M $35.29 192
2024 Q1 95.3M $2.71B +$816M $28.39 167
2023 Q4 38.8K $516K -$441K $13.30 1
2023 Q3 59.9M $537M +$3.88M $8.96 114
2023 Q2 59M $664M +$48.6M $11.25 116
2023 Q1 54.6M $628M +$56.4M $11.52 124
2022 Q4 49.7M $576M +$50.4M $11.59 110
2022 Q3 42.7M $542M -$9.31M $12.70 95
2022 Q2 46.4M $319M -$7.88M $6.87 84
2022 Q1 46.9M $452M -$3.42M $9.64 87
2021 Q4 47.8M $568M +$18.8M $11.89 89
2021 Q3 32.2M $523M -$18M $16.24 79
2021 Q2 32.9M $692M +$24.4M $21.04 73
2021 Q1 31.4M $487M +$66M $15.53 72
2020 Q4 25.3M $532M +$16.5M $21.00 64
2020 Q3 24.2M $488M +$488M $20.19 48